Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Leuprolide versus Variopeptyl for uterine fibroids
IRCT20251202068183N1Phase 2Recruiting
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Jan 2026
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of leuprolide in Fibromyoma (LM) (2 arms), sponsored by Tabriz University of Medical Sciences. Primary endpoints: Menstrual blood loss and Size of myomas. Started Jan 2026; status: recruiting.
02
Drugs
leuprolide
03
Conditions
Fibromyoma (LM)
Beyond the preview
Go deeper on IRCT20251202068183N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20251202068183N1.